uniQure (QURE) Other Non-Current Assets (2015 - 2026)
uniQure (QURE) posted quarterly Other Non-Current Assets of $4.5 million for Q2 2026, down 17.46% year-over-year from $5.5 million in Q2 2025, and down 18.17% quarter-over-quarter from $5.5 million in Q1 2026.
uniQure (QURE) Other Non-Current Assets (2015 - 2026) Analysis & Trends
uniQure's Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $4.5 million for Q2 2026.
- In Q2 2026, Other Non-Current Assets fell 17.46% year-over-year to $4.5 million; the TTM figure through Jun 2026 stood at $4.5 million (down 17.46% YoY), while the FY2025 annual figure was $5.6 million, up 297.5% from the prior year.
- Other Non-Current Assets for Q2 2026 stood at $4.5 million, down from $5.5 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $38.0 million in Q2 2024, with the low at $1.4 million in Q4 2024.
- The 5-year median for Other Non-Current Assets is $5.6 million (2025), against an average of $6.9 million.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets soared 519.92% in 2024, then plunged 85.53% in 2025.
- uniQure's Other Non-Current Assets stood at $6.1 million in 2022, then plunged by 47.47% to $3.2 million in 2023, then slumped by 56.06% to $1.4 million in 2024, then soared by 297.5% to $5.6 million in 2025, then decreased by 18.45% to $4.5 million in 2026.
- Business Quant data shows QURE's Other Non-Current Assets at $4.5 million in Q2 2026, $5.5 million in Q1 2026, and $5.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | 4.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.54 Mn |
| Mar 31, 2026 | 5.54 Mn |
| Dec 31, 2025 | 5.56 Mn |
| Sep 30, 2025 | 5.49 Mn |
| Jun 30, 2025 | 5.49 Mn |
| Mar 31, 2025 | 5.43 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 37.96 Mn |
| Mar 31, 2024 | 5.30 Mn |
| Dec 31, 2023 | 3.18 Mn |
| Sep 30, 2023 | 6.02 Mn |
| Jun 30, 2023 | 6.12 Mn |
| Mar 31, 2023 | 6.12 Mn |
| Dec 31, 2022 | 6.06 Mn |
| Sep 30, 2022 | 6.09 Mn |
| Jun 30, 2022 | 5.97 Mn |
| Mar 31, 2022 | 5.94 Mn |
| Dec 31, 2021 | 5.90 Mn |
| Sep 30, 2021 | 5.67 Mn |